abstract |
Use of entacapone, an entacapone derivative or a stereoisomer, hydride, or pharmaceutically-acceptable salt thereof, in a person in need thereof, in treating or inhibiting macular degeneration or age-related macular degeneration. And the pharmaceutical composition or formulation comprising entacapone, an entacapone derivative or a stereoisomer, hydride, or pharmaceutically-acceptable salt thereof. |